New International Working Group Answers COVID-19 Questions from Myasthenia Gravis Patients
source: pixabay.com

New International Working Group Answers COVID-19 Questions from Myasthenia Gravis Patients

  New information, speculation, statistics, and predictions about COVID-19 are hitting the internet every day. Yet neurologists are attempting to answer their patients’ questions without having sufficient data that would…

Continue Reading New International Working Group Answers COVID-19 Questions from Myasthenia Gravis Patients
Here’s How Coronavirus/COVID-19 Could Impact Multiple Sclerosis Patients
source: pixabay.com

Here’s How Coronavirus/COVID-19 Could Impact Multiple Sclerosis Patients

According to a story from NeurologyLive, patients being treated for autoimmune diseases such as multiple sclerosis (MS) or myasthenia gravis could be at heightened risk of infection with coronavirus because…

Continue Reading Here’s How Coronavirus/COVID-19 Could Impact Multiple Sclerosis Patients

Catalyst is Meeting with the FDA to Discuss the Future of Firdapse for Congenital Myasthenic Syndromes

Firdapse, or amifampridine phosphate, is a medication currently approved for Lambert-Eaton myasthenic syndrome, or LEMS. However, Catalyst Pharmaceuticals has been working to evaluate if it can aid other neurological and…

Continue Reading Catalyst is Meeting with the FDA to Discuss the Future of Firdapse for Congenital Myasthenic Syndromes

“When You Have to, You Can:” a Myasthenia Gravis Story From the Czech Republic

"It’s like when you suddenly shut off control over your muscles. Your will can’t affect it at all. “I say that I’m a ‘physical schizophrenic,’ and I can only do…

Continue Reading “When You Have to, You Can:” a Myasthenia Gravis Story From the Czech Republic

Myasthenia Gravis Patient Didn’t Let Diagnosis Stop Her from Running in the 2019 Boston Marathon

When you’re diagnosed with a rare condition it can change the entire course of your life, at least at the beginning. But those living with diseases like these are fighters.…

Continue Reading Myasthenia Gravis Patient Didn’t Let Diagnosis Stop Her from Running in the 2019 Boston Marathon
Study Highlights Long Term Benefits of Thymectomy Surgery for Myasthenia Gravis Patients
skeeze / Pixabay

Study Highlights Long Term Benefits of Thymectomy Surgery for Myasthenia Gravis Patients

According to a story from EurekAlert!, a recent study revealed that the surgical removal of the thymus gland, known as a thymectomy, was able to provide long-term benefits for patients…

Continue Reading Study Highlights Long Term Benefits of Thymectomy Surgery for Myasthenia Gravis Patients

Positive Results From a Phase IIb Trial of Firdapse for MuSK Myasthenia Gravis Published Online

Myasthenia Gravis (MG) is a progressive autoimmune disorder which results in the weakening of muscles. Most people with the condition are able to manage their symptoms with treatment and have…

Continue Reading Positive Results From a Phase IIb Trial of Firdapse for MuSK Myasthenia Gravis Published Online
Global Phase 3 Trial For Experimental Myasthenia Gravis Treatment to Begin Before The End of The Year
mwooten / Pixabay

Global Phase 3 Trial For Experimental Myasthenia Gravis Treatment to Begin Before The End of The Year

According to a story from Euroinvestor, the biotechnology company argenx recently announced that it has gotten correspondence from Japan's Pharmaceuticals and Medical Devices Agency (PMDA) in regards to the design…

Continue Reading Global Phase 3 Trial For Experimental Myasthenia Gravis Treatment to Begin Before The End of The Year
Advocates Unite to Create New Center for Autoimmune Patients
Source: Pixabay

Advocates Unite to Create New Center for Autoimmune Patients

A new partnership between two major players in autoimmune disease research recently hit the news. The American Autoimmune Related Disease Association (AARDA) announced a partnership with Allegheny Health Network (AHN).…

Continue Reading Advocates Unite to Create New Center for Autoimmune Patients
Check out these Invaluable Resources for Myasthenia Gravis Awareness Month!
3dman_eu / Pixabay

Check out these Invaluable Resources for Myasthenia Gravis Awareness Month!

June is here - and so is Myasthenia Gravis Awareness Month! What is Myasthenia Gravis you say? Myasthenia Gravis (MG) is an autoimmune neuromuscular disorder characterized by weakness and rapid fatigue of any of…

Continue Reading Check out these Invaluable Resources for Myasthenia Gravis Awareness Month!
Myasthenia Gravis Treatment Gets Orphan Drug Designation in EU
source: pixabay.com

Myasthenia Gravis Treatment Gets Orphan Drug Designation in EU

According to a story from GlobeNewswire, the biotechnology company argenx announced recently that its investigational therapy ARGX-113 was granted orphan drug status by the European Commission. This designation is based…

Continue Reading Myasthenia Gravis Treatment Gets Orphan Drug Designation in EU
Close Menu